Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease

Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study

(2018) Ingo Kilimann et al.   JOURNAL OF ALZHEIMERS DISEASE

Anti-Inflammatory Action of Donepezil Ameliorates Tau Pathology, Synaptic Loss, and Neurodegeneration in a Tauopathy Mouse Model

(2017) Yasumasa Yoshiyama et al.   JOURNAL OF ALZHEIMERS DISEASE

Efficacy of lifestyle interventions on clinical and neuroimaging outcomes in elderly

(2016) Elena Rolandi et al.   AGEING RESEARCH REVIEWS

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease

(2016) Enrica Cavedo et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and 1H-MRS

(2016) Chung-Man Moon et al.   MAGNETIC RESONANCE IMAGING

Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease

(2016) Stefan J. Teipel et al.   NEUROPHARMACOLOGY

Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study

(2016) Arun L.W. Bokde et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

(2016) Taylor W. Schmitz et al.   Nature Communications

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

(2015) Bruno Dubois et al.   Alzheimers & Dementia

Lifelong bilingualism and neural reserve against Alzheimer's disease: A review of findings and potential mechanisms

(2015) Brian T. Gold   BEHAVIOURAL BRAIN RESEARCH

Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment

(2015) Michel J. Grothe et al.   CEREBRAL CORTEX

Basal Forebrain Atrophy Contributes to Allocentric Navigation Impairment in Alzheimer’s Disease Patients

(2015) Georg M. Kerbler et al.   Frontiers in Aging Neuroscience

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease

(2015) J. Thomas et al.   Biomed Research International

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease

(2015) Georg M Kerbler et al.   NeuroImage-Clinical

Early neurone loss in Alzheimer’s disease: cortical or subcortical?

(2015) Thomas Arendt et al.   Acta Neuropathologica Communications

Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects

(2014) Michel J. Grothe et al.   Alzheimers & Dementia

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

(2014) Deborah Doens et al.   Journal of Neuroinflammation

Donepezil Treatment Stabilizes Functional Connectivity During Resting State and Brain Activity During Memory Encoding in Alzheimer’s Disease

(2013) Cristina Solé-Padullés et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease

(2013) M.-Marsel Mesulam   JOURNAL OF COMPARATIVE NEUROLOGY

Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease

(2013) Stefan Teipel et al.   NEUROBIOLOGY OF AGING

Association of basal forebrain volumes and cognition in normal aging

(2013) D. Wolf et al.   NEUROPSYCHOLOGIA

Symmetric diffeomorphic modeling of longitudinal structural MRI

(2013) John Ashburner   Frontiers in Neuroscience

Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease

(2012) Michel Grothe et al.   NEUROBIOLOGY OF AGING

A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

(2012) Jose Miguel Rubio-Perez et al.   TheScientificWorldJOURNAL

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease

(2011) Pamela E. Potter et al.   ACTA NEUROPATHOLOGICA

Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease

(2011) Michel Grothe et al.   BIOLOGICAL PSYCHIATRY

Recovery of hippocampal network connectivity correlates with cognitive improvement in mild alzheimer's disease patients treated with donepezil assessed by resting-state fMRI

(2011) Joseph S. Goveas et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study

(2010) Stefan J. Teipel et al.   HUMAN BRAIN MAPPING

Alzheimer's disease: clinical trials and drug development

(2010) Francesca Mangialasche et al.   LANCET NEUROLOGY

An MRI substudy of a donepezil clinical trial in mild cognitive impairment

(2010) Norbert Schuff et al.   NEUROBIOLOGY OF AGING

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

(2010) H. H. Feldman et al.   NEUROLOGY

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

(2009) N. Schuff et al.   BRAIN

Basal forebrain integrity and cognitive memory profile in healthy aging

(2009) Sandra Düzel et al.   BRAIN RESEARCH

Reduction of Basal Forebrain Cholinergic System Parallels Cognitive Impairment in Patients at High Risk of Developing Alzheimer's Disease

(2009) M. Grothe et al.   CEREBRAL CORTEX

Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation

(2009) M. Chupin et al.   NEUROIMAGE

Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial

(2009) R. S. Doody et al.   NEUROLOGY

Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI

(2007) Clifford R. Jack et al.   NEUROBIOLOGY OF AGING